Show Summary Details
Page of

Pathogenesis of Infantile Hemangioma 

Pathogenesis of Infantile Hemangioma
Pathogenesis of Infantile Hemangioma

John B. Mulliken

and Joyce Bischoff

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 10 April 2020

Infantile hemangioma’s curious biological behavior of rapid growth and slow regression entices researchers and clinicians alike. Basic investigative techniques have progressed well beyond traditional light microscopy and hematoxylin/eosin staining. The three phases of hemangioma’s life cycle (proliferation, involution, and involuted) have been examined using immunohistochemistry to portray protein expression and PCR-based differential display, in situ hybridization and microarray to quantitate mRNA expression. The major cellular phenotypes on stage of the hemangiomatous drama have been indentified by flow cytometry and further studied in tissue culture. A murine model has exposed a subpopulation of hemangioma stem cells and has been used to determine the mechanism of drug treatments. Molecular genetic studies given strong evidence that hemangioma begins as a somatic mutation in a primitive cell type.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.